{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:15:07Z","timestamp":1793823307585,"version":"4.6.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03201-4","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T16:13:59Z","timestamp":1778084039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Associations of nine insulin resistance-related indices with the incidence and progression of cardiovascular-liver-metabolic multimorbidity: a large prospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Chaonan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qida","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueping","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"issue":"6","key":"3201_CR1","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1016\/S2214-109X(20)30127-3","volume":"8","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Atun R, Oldenburg B, McPake B, Tang S, Mercer SW, et al. Physical multimorbidity, health service use, and catastrophic health expenditure by socioeconomic groups in China: an analysis of population-based panel data. Lancet Glob Health. 2020;8(6):e840\u20139.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"3201_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1001\/jama.2015.7008","volume":"314","author":"E Di Angelantonio","year":"2015","unstructured":"Di Angelantonio E, Kaptoge S, Wormser D, Willeit P, Butterworth AS, Bansal N, et al. Association of cardiometabolic multimorbidity with mortality. JAMA. 2015;314(1):52\u201360.","journal-title":"JAMA"},{"issue":"4","key":"3201_CR3","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.arr.2011.03.003","volume":"10","author":"A Marengoni","year":"2011","unstructured":"Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, et al. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev. 2011;10(4):430\u20139.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"3201_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12933-025-02819-0","volume":"24","author":"Z Tian","year":"2025","unstructured":"Tian Z, Yang L, Li Y, Huang Y, Yang J, Xue F. Associations of different insulin resistance-related indices with the incidence and progression trajectory of cardiometabolic multimorbidity: a prospective cohort study from UK biobank. Cardiovasc Diabetol. 2025;24(1):257.","journal-title":"Cardiovasc Diabetol"},{"issue":"34","key":"3201_CR5","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1093\/eurheartj\/ehab413","volume":"42","author":"Y Han","year":"2021","unstructured":"Han Y, Hu Y, Yu C, Guo Y, Pei P, Yang L, et al. Lifestyle, cardiometabolic disease, and multimorbidity in a prospective Chinese study. Eur Heart J. 2021;42(34):3374\u201384.","journal-title":"Eur Heart J"},{"issue":"1","key":"3201_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12933-024-02347-3","volume":"23","author":"N Zhang","year":"2024","unstructured":"Zhang N, Liu X, Wang L, Zhang Y, Xiang Y, Cai J, et al. Lifestyle factors and their relative contributions to longitudinal progression of cardio-renal-metabolic multimorbidity: a prospective cohort study. Cardiovasc Diabetol. 2024;23(1):265.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3201_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/s12933-025-02928-w","volume":"24","author":"L Liu","year":"2025","unstructured":"Liu L, Yu G, Ji X, Wang Y, He H. Associations of six insulin resistance-related indices with the risk and progression of cardio-renal-metabolic multimorbidity: evidence from the UK biobank. Cardiovasc Diabetol. 2025;24(1):377.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3201_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12933-025-02693-w","volume":"24","author":"H Tang","year":"2025","unstructured":"Tang H, Huang J, Zhang X, Chen X, Yang Q, Luo N, et al. Association between triglyceride glucose-body mass index and the trajectory of cardio-renal-metabolic multimorbidity: insights from multi-state modelling. Cardiovasc Diabetol. 2025;24(1):133.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3201_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.124.070535","volume":"151","author":"NWS Chew","year":"2025","unstructured":"Chew NWS, Mehta A, Goh RSJ, Zhang A, Chen Y, Chong B, et al. Cardiovascular-liver-metabolic health: recommendations in screening, diagnosis, and management of metabolic dysfunction-associated steatotic liver disease in cardiovascular disease via modified Delphi approach. Circulation. 2025;151(1):98\u2013119.","journal-title":"Circulation"},{"key":"3201_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41569-025-01220-4","volume":"23","author":"NWS Chew","year":"2025","unstructured":"Chew NWS, Mehta A, Goh R, Koh J, Chen Y, Chong B, et al. The global cardiovascular-liver-metabolic syndemic: epidemiology, trends and challenges. Nat Rev Cardiol. 2025;23:219.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"3201_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12933-022-01546-0","volume":"21","author":"X Liu","year":"2022","unstructured":"Liu X, Tan Z, Huang Y, Zhao H, Liu M, Yu P, et al. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):124.","journal-title":"Cardiovasc Diabetol"},{"key":"3201_CR12","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.2147\/DMSO.S478287","volume":"17","author":"Y Pan","year":"2024","unstructured":"Pan Y, Zhao M, Song T, Tang J, Kuang M, Liu H, et al. Role of triglyceride-glucose index in type 2 diabetes mellitus and Its complications. Diabetes Metab Syndr Obes. 2024;17:3325\u201333.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"5","key":"3201_CR13","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1111\/dom.70536","volume":"28","author":"XM Wang","year":"2026","unstructured":"Wang XM, Yan H, Zhong WF, Xie JH, Chen H, Wang JJ, et al. Association of four insulin resistance indices with liver-related adverse outcomes: A prospective cohort study. Diabetes Obes Metab. 2026;28(5):3598\u2013611.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"3201_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018. Cardiovasc Diabetol. 2024;23(1):8.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"3201_CR15","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3390\/biomedicines13061291","volume":"13","author":"AD Brie","year":"2025","unstructured":"Brie AD, Christodorescu RM, Popescu R, Adam O, T\u00eerziu A, Brie DM. Atherosclerosis and insulin resistance: is there a link between them? Biomedicines. 2025;13(6):1291.","journal-title":"Biomedicines."},{"issue":"1","key":"3201_CR16","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-022-01073-0","volume":"7","author":"M Li","year":"2022","unstructured":"Li M, Chi X, Wang Y, Setrerrahmane S, Xie W, Xu H. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct Target Ther. 2022;7(1):216.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"3201_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.numecd.2009.07.007","volume":"20","author":"M Matsuda","year":"2010","unstructured":"Matsuda M. Measuring and estimating insulin resistance in clinical and research settings. Nutr Metab Cardiovasc Dis. 2010;20(2):79\u201386.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"7","key":"3201_CR18","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M, Mart\u00ednez-Abundis E, Ramos-Zavala MG, Hern\u00e1ndez-Gonz\u00e1lez SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347\u201351.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3201_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12933-024-02571-x","volume":"24","author":"Y Huang","year":"2025","unstructured":"Huang Y, Zhou Y, Xu Y, Wang X, Zhou Z, Wu K, et al. Inflammatory markers link triglyceride-glucose index and obesity indicators with adverse cardiovascular events in patients with hypertension: insights from three cohorts. Cardiovasc Diabetol. 2025;24(1):11.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3201_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12933-024-02572-w","volume":"24","author":"Y Qiao","year":"2025","unstructured":"Qiao Y, Wang Y, Chen C, Huang Y, Zhao C. Association between triglyceride-glucose (TyG) related indices and cardiovascular diseases and mortality among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study of UK Biobank. Cardiovasc Diabetol. 2025;24(1):12.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3201_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12933-025-02854-x","volume":"24","author":"Y Yue","year":"2025","unstructured":"Yue Y, Li P, Sun Z, Murayama R, Li Z, Hashimoto K, et al. Association of novel triglyceride-glucose-related indices with incident stroke in early-stage cardiovascular-kidney-metabolic syndrome. Cardiovasc Diabetol. 2025;24(1):301.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3201_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12933-026-03077-4","volume":"25","author":"T Jin","year":"2026","unstructured":"Jin T, Tang X, Han Y, Fan H, Qin Q, Jiang H, et al. Relationship between nine triglyceride-glucose-related indices and cardiometabolic multimorbidity incidence in patients with cardiovascular-kidney-metabolic syndrome stage 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2026;25(1):36.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3201_CR23","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12933-025-02902-6","volume":"24","author":"X Zheng","year":"2025","unstructured":"Zheng X, Zhang W, Yang F, Wang L, Yu B, Liang B. Evaluative performance of TyG-ABSI versus traditional indices in relation to cardiovascular disease and mortality: evidence from the U.S. NHANES. Cardiovasc Diabetol. 2025;24(1):344.","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"3201_CR24","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s00592-025-02499-y","volume":"62","author":"W Bai","year":"2025","unstructured":"Bai W, Chen H, Wan H, Ye X, Ling Y, Xu J, et al. Association between the triglyceride glucose-body roundness index and the incidence of cardiovascular disease among Chinese middle and old-aged adults: a nationwide prospective cohort study. Acta Diabetol. 2025;62(10):1647\u201357.","journal-title":"Acta Diabetol"},{"issue":"1","key":"3201_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12933-025-02896-1","volume":"24","author":"Y Fan","year":"2025","unstructured":"Fan Y, Ye D, Zhou K, Cai L, Yu L. The novel triglyceride-glucose-weighted adjusted waist index as a supplementary diagnostic tool for heart failure: evidence of improved reclassification beyond traditional TyG-related indices from a cross-sectional study. Cardiovasc Diabetol. 2025;24(1):329.","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"3201_CR26","doi-asserted-by":"publisher","first-page":"e1004310","DOI":"10.1371\/journal.pmed.1004310","volume":"20","author":"S Chen","year":"2023","unstructured":"Chen S, Marshall T, Jackson C, Cooper J, Crowe F, Nirantharakumar K, et al. Sociodemographic characteristics and longitudinal progression of multimorbidity: A multistate modelling analysis of a large primary care records dataset in England. PLoS Med. 2023;20(11):e1004310.","journal-title":"PLoS Med"},{"key":"3201_CR27","doi-asserted-by":"crossref","unstructured":"Skou ST, Mair FS, Fortin M, Guthrie B, Nunes BP, Miranda JJ, et al. Multimorbidity. Nat Rev Dis Primers. 2022; 8(1):48.","DOI":"10.1038\/s41572-022-00376-4"},{"issue":"3","key":"3201_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.cmpb.2010.01.001","volume":"99","author":"LC de Wreede","year":"2010","unstructured":"de Wreede LC, Fiocco M, Putter H. The mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks models. Comput Methods Programs Biomed. 2010;99(3):261\u201374.","journal-title":"Comput Methods Programs Biomed"},{"issue":"1","key":"3201_CR29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12933-023-02030-z","volume":"22","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Xiao S, Jiao X, Shen Y. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001-2018. Cardiovasc Diabetol. 2023;22(1):279.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3201_CR30","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12933-025-02758-w","volume":"24","author":"X Gao","year":"2025","unstructured":"Gao X, Chen T, Zhou F, Sun Y, Zhang J, Li X, et al. The association between different insulin resistance surrogates and all-cause mortality and cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2025;24(1):200.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"3201_CR31","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779.","journal-title":"PLoS Med"},{"issue":"3","key":"3201_CR32","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jhep.2024.08.024","volume":"82","author":"Q Zhong","year":"2025","unstructured":"Zhong Q, Zhou R, Huang YN, Huang RD, Li FR, Chen HW, et al. Frailty and risk of metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases. J Hepatol. 2025;82(3):427\u201337.","journal-title":"J Hepatol"},{"issue":"2","key":"3201_CR33","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/ije\/dym276","volume":"37","author":"P Elliott","year":"2008","unstructured":"Elliott P, Peakman TC. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol. 2008;37(2):234\u201344.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"3201_CR34","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12933-025-02967-3","volume":"24","author":"Z Xiao","year":"2025","unstructured":"Xiao Z, Luo L, Weng W, Yu E, Zheng J, Pan X, et al. Elevated triglyceride-glucose index and its combination with anthropometric indices as indicators of the risk of new-onset transient ischemic attack: a prospective cohort study. Cardiovasc Diabetol. 2025;24(1):420.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"3201_CR35","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1001\/jama.2019.9879","volume":"322","author":"I Lourida","year":"2019","unstructured":"Lourida I, Hannon E, Littlejohns TJ, Langa KM, Hypp\u00f6nen E, Kuzma E, et al. Association of lifestyle and genetic risk with incidence of dementia. JAMA. 2019;322(5):430\u20137.","journal-title":"JAMA"},{"key":"3201_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-026-03112-4","author":"G Yang","year":"2026","unstructured":"Yang G, He W, Qiu X, Shen S, Li P, Feng Y, et al. Triglyceride glucose index-a body shape index (TyG-ABSI) outperforms traditional obesity indices in predicting all-cause and cardiovascular mortality in metabolic-dysfunction associated steatotic liver disease: the mediating role of biological aging. Cardiovasc Diabetol. 2026. https:\/\/doi.org\/10.1186\/s12933-026-03112-4.","journal-title":"Cardiovasc Diabetol"},{"issue":"28","key":"3201_CR37","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1002\/sim.7340","volume":"36","author":"NR Cook","year":"2017","unstructured":"Cook NR, Demler OV, Paynter NP. Clinical risk reclassification at 10\u00a0years. Stat Med. 2017;36(28):4498\u2013502.","journal-title":"Stat Med"},{"issue":"19","key":"3201_CR38","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1002\/sim.5804","volume":"33","author":"J Hilden","year":"2014","unstructured":"Hilden J, Gerds TA. A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index. Stat Med. 2014;33(19):3405\u201314.","journal-title":"Stat Med"},{"key":"3201_CR39","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1146\/annurev.psych.58.110405.085542","volume":"58","author":"DP MacKinnon","year":"2007","unstructured":"MacKinnon DP, Fairchild AJ, Fritz MS. Mediation analysis. Annu Rev Psychol. 2007;58:593\u2013614.","journal-title":"Annu Rev Psychol"},{"issue":"1","key":"3201_CR40","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1186\/s12933-024-02494-7","volume":"23","author":"H Raeisi-Dehkordi","year":"2024","unstructured":"Raeisi-Dehkordi H, Thorand B, Beigrezaei S, Peters A, Rathman W, Adamski J, et al. The mediatory role of androgens on sex differences in glucose homeostasis and incidence of type 2 diabetes: the KORA study. Cardiovasc Diabetol. 2024;23(1):411.","journal-title":"Cardiovasc Diabetol"},{"key":"3201_CR41","doi-asserted-by":"publisher","first-page":"102539","DOI":"10.1016\/j.eclinm.2024.102539","volume":"70","author":"FCT van der Heide","year":"2024","unstructured":"van der Heide FCT, Valeri L, Dugravot A, Danilevicz I, Landre B, Kivimaki M, et al. Role of cardiovascular health factors in mediating social inequalities in the incidence of dementia in the UK: two prospective, population-based cohort studies. EClinicalMedicine. 2024;70:102539.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"3201_CR42","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/s12933-025-02961-9","volume":"24","author":"J Hu","year":"2025","unstructured":"Hu J, Shang C, Huang Y, Sun C, Zhang J. Insulin resistance-related indices, genetic risk, and the risk of cardiovascular disease in individuals with preclinical or clinical obesity: a large prospective cohort study in the UK Biobank. Cardiovasc Diabetol. 2025;24(1):407.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"3201_CR43","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1097\/EDE.0000000000001378","volume":"32","author":"B Shi","year":"2021","unstructured":"Shi B, Choirat C, Coull BA, VanderWeele TJ, Valeri L. CMAverse: a suite of functions for reproducible causal mediation analyses. Epidemiology. 2021;32(5):e20\u20132.","journal-title":"Epidemiology"},{"issue":"2","key":"3201_CR44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/0962280208092301","volume":"18","author":"L Meira-Machado","year":"2009","unstructured":"Meira-Machado L, de U\u00f1a-Alvarez J, Cadarso-Su\u00e1rez C, Andersen PK. Multi-state models for the analysis of time-to-event data. Stat Methods Med Res. 2009;18(2):195\u2013222.","journal-title":"Stat Methods Med Res"},{"issue":"4","key":"3201_CR45","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377\u201399.","journal-title":"Stat Med"},{"issue":"15","key":"3201_CR46","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1002\/sim.3618","volume":"28","author":"IR White","year":"2009","unstructured":"White IR, Royston P. Imputing missing covariate values for the Cox model. Stat Med. 2009;28(15):1982\u201398.","journal-title":"Stat Med"},{"issue":"6","key":"3201_CR47","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u201356.","journal-title":"J Hepatol"},{"key":"3201_CR48","doi-asserted-by":"publisher","first-page":"101116","DOI":"10.1016\/j.jshs.2025.101116","volume":"15","author":"MA Sanchez-Lastra","year":"2025","unstructured":"Sanchez-Lastra MA, Del Pozo CB, Tarp J, Dalene KE, Nilsen TS, Ding D, et al. Dose-response associations of self-reported and device-measured physical activity with major adverse cardiovascular events in people with prevalent diseases. J Sport Health Sci. 2025;15:101116.","journal-title":"J Sport Health Sci"},{"key":"3201_CR49","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jad.2025.04.072","volume":"382","author":"J Liu","year":"2025","unstructured":"Liu J, Liu Z, Zhou Y, Liu Y, Song W, Wang N, et al. The joint effect of triglyceride-glucose related indices and depression on cardio-renal-metabolic multimorbidity among middle-aged and older Chinese adults. J Affect Disord. 2025;382:549\u201357.","journal-title":"J Affect Disord"},{"issue":"1","key":"3201_CR50","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12933-024-02287-y","volume":"23","author":"Y Min","year":"2024","unstructured":"Min Y, Wei X, Wei Z, Song G, Zhao X, Lei Y. Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2024;23(1):188.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3201_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12944-025-02836-8","volume":"25","author":"F Zhang","year":"2025","unstructured":"Zhang F, Zhang B, Huang X, Wang Z, Wang J, Lan H, et al. Comparison of the TyG index, TyG-traditional obesity indices, and TyG-novel obesity indices: does increased complexity help in predicting cardiometabolic multimorbidity? Lipids Health Dis. 2025;25(1):33.","journal-title":"Lipids Health Dis"},{"issue":"7121","key":"3201_CR52","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/nature05482","volume":"444","author":"SE Kahn","year":"2006","unstructured":"Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840\u20136.","journal-title":"Nature"},{"issue":"2","key":"3201_CR53","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1093\/ajcn\/nqaa331","volume":"113","author":"L Wang","year":"2021","unstructured":"Wang L, Lee Y, Wu Y, Zhang X, Jin C, Huang Z, et al. A prospective study of waist circumference trajectories and incident cardiovascular disease in China: the Kailuan Cohort Study. Am J Clin Nutr. 2021;113(2):338\u201347.","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"3201_CR54","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1467-789X.2011.00952.x","volume":"13","author":"M Ashwell","year":"2012","unstructured":"Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13(3):275\u201386.","journal-title":"Obes Rev"},{"issue":"13","key":"3201_CR55","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1161\/CIRCULATIONAHA.107.739714","volume":"117","author":"C Zhang","year":"2008","unstructured":"Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation. 2008;117(13):1658\u201367.","journal-title":"Circulation"},{"issue":"1","key":"3201_CR56","doi-asserted-by":"publisher","first-page":"e230245","DOI":"10.1530\/JOE-23-0245","volume":"261","author":"M Gado","year":"2024","unstructured":"Gado M, Tsaousidou E, Bornstein SR, Perakakis N. Sex-based differences in insulin resistance. J Endocrinol. 2024;261(1):e230245.","journal-title":"J Endocrinol"},{"issue":"5","key":"3201_CR57","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","volume":"148","author":"VT Samuel","year":"2012","unstructured":"Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012;148(5):852\u201371.","journal-title":"Cell"},{"key":"3201_CR58","doi-asserted-by":"publisher","first-page":"1692742","DOI":"10.3389\/fimmu.2025.1692742","volume":"16","author":"S Saadati","year":"2025","unstructured":"Saadati S, Godini R, Reddy A, Teede H, Mousa A. Metabolic crossroads in insulin resistance: exploring lipid dysregulation and inflammation. Front Immunol. 2025;16:1692742.","journal-title":"Front Immunol"},{"key":"3201_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/biom15121745","author":"A Lonardo","year":"2025","unstructured":"Lonardo A, Weiskirchen R. Insulin resistance at the crossroads of metabolic inflammation, cardiovascular disease, organ failure and cancer. Biomolecules. 2025. https:\/\/doi.org\/10.3390\/biom15121745.","journal-title":"Biomolecules"},{"key":"3201_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58010004","author":"AL Kurniawan","year":"2021","unstructured":"Kurniawan AL, Hsu CY, Chao JC, Paramastri R, Lee HA, Jallow AW. Association of two indices of insulin resistance marker with abnormal liver function tests: a cross-sectional population study in Taiwanese adults. Medicina (Kaunas). 2021. https:\/\/doi.org\/10.3390\/medicina58010004.","journal-title":"Medicina (Kaunas)"},{"key":"3201_CR61","doi-asserted-by":"publisher","first-page":"1570239","DOI":"10.3389\/fcvm.2025.1570239","volume":"12","author":"J Xie","year":"2025","unstructured":"Xie J, Pei X, Zhu S, Jiang W, Tang H, Wu D, et al. Association of triglyceride-glucose-related indices with adverse clinical outcomes in individuals with normal body mass index. Front Cardiovasc Med. 2025;12:1570239.","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"3201_CR62","doi-asserted-by":"publisher","first-page":"e00481","DOI":"10.1002\/edm2.481","volume":"7","author":"A Hasan","year":"2024","unstructured":"Hasan A, Newaj A, Trisha AD, Hafsa JM, Mohanto NC, Ali N. Assessment of the relationship between liver enzymes and cardiovascular disease: a study in Bangladeshi adults. Endocrinol Diabetes Metab. 2024;7(2):e00481.","journal-title":"Endocrinol Diabetes Metab"},{"key":"3201_CR63","doi-asserted-by":"publisher","first-page":"1280185","DOI":"10.3389\/fpubh.2023.1280185","volume":"11","author":"Y Jin","year":"2023","unstructured":"Jin Y, Xu Z, Zhang Y, Zhang Y, Wang D, Cheng Y, et al. Serum\/plasma biomarkers and the progression of cardiometabolic multimorbidity: a systematic review and meta-analysis. Front Public Health. 2023;11:1280185.","journal-title":"Front Public Health"},{"key":"3201_CR64","doi-asserted-by":"publisher","first-page":"172657","DOI":"10.1016\/j.ejphar.2019.172657","volume":"862","author":"BM Patel","year":"2019","unstructured":"Patel BM, Goyal RK. Liver and insulin resistance: new wine in old bottle!!! Eur J Pharmacol. 2019;862:172657.","journal-title":"Eur J Pharmacol"},{"key":"3201_CR65","doi-asserted-by":"publisher","first-page":"1038758","DOI":"10.3389\/fendo.2022.1038758","volume":"13","author":"J Dong","year":"2022","unstructured":"Dong J, Yang H, Zhang Y, Chen L, Hu Q. A high triglyceride glucose index is associated with early renal impairment in the hypertensive patients. Front Endocrinol (Lausanne). 2022;13:1038758.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3201_CR66","doi-asserted-by":"publisher","first-page":"111705","DOI":"10.1016\/j.diabres.2024.111705","volume":"212","author":"S Liu","year":"2024","unstructured":"Liu S, Sun H, Liu J, Wang G. Accessing the relationship between six surrogate insulin resistance indexes and the incidence of rapid kidney function decline and the progression to chronic kidney disease among middle-aged and older adults in China: results from the China health and retirement longitudinal study. Diabetes Res Clin Pract. 2024;212:111705.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"3201_CR67","doi-asserted-by":"publisher","first-page":"2427907","DOI":"10.1080\/07853890.2024.2427907","volume":"56","author":"X Xu","year":"2024","unstructured":"Xu X, Ma R, Zhang X, Guo H, Keerman M, Wang X, et al. Association between renal function trajectories and risk of cardiovascular disease: a prospective cohort study. Ann Med. 2024;56(1):2427907.","journal-title":"Ann Med"},{"key":"3201_CR68","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.ijcard.2015.09.090","volume":"202","author":"TC Turin","year":"2016","unstructured":"Turin TC, Jun M, James MT, Tonelli M, Coresh J, Manns BJ, et al. Magnitude of rate of change in kidney function and future risk of cardiovascular events. Int J Cardiol. 2016;202:657\u201365.","journal-title":"Int J Cardiol"},{"key":"3201_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-026-02174-5","author":"M Arikawa","year":"2026","unstructured":"Arikawa M, Saita M, Yokokawa H, Takahashi Y, Fukuda H, Naito T. Positive association between serum uric acid and metabolic dysfunction-associated steatotic liver disease: insights from a Japanese health checkup cohort. BMC Endocr Disord. 2026. https:\/\/doi.org\/10.1186\/s12902-026-02174-5.","journal-title":"BMC Endocr Disord"},{"issue":"3","key":"3201_CR70","doi-asserted-by":"publisher","first-page":"648","DOI":"10.5114\/aoms.2019.83511","volume":"16","author":"CC Ma","year":"2020","unstructured":"Ma CC, Duan CC, Huang RC, Tang HQ. Association of circulating cystatin C levels with type 2 diabetes mellitus: a systematic review and meta-analysis. Arch Med Sci. 2020;16(3):648\u201356.","journal-title":"Arch Med Sci"},{"issue":"12","key":"3201_CR71","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrneph.2016.145","volume":"12","author":"F Artunc","year":"2016","unstructured":"Artunc F, Schleicher E, Weigert C, Fritsche A, Stefan N, H\u00e4ring HU. The impact of insulin resistance on the kidney and vasculature. Nat Rev Nephrol. 2016;12(12):721\u201337.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"3201_CR72","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000479801","volume":"8","author":"A Whaley-Connell","year":"2017","unstructured":"Whaley-Connell A, Sowers JR. Insulin resistance in kidney disease: is there a distinct role separate from that of diabetes or obesity? Cardiorenal Med. 2017;8(1):41\u20139.","journal-title":"Cardiorenal Med"},{"issue":"1","key":"3201_CR73","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000542965","volume":"15","author":"L Lo Cicero","year":"2025","unstructured":"Lo Cicero L, Lentini P, Sessa C, Castellino N, D\u2019Anca A, Torrisi I, et al. Inflammation and arterial stiffness as drivers of cardiovascular risk in kidney disease. Cardiorenal Med. 2025;15(1):29\u201340.","journal-title":"Cardiorenal Med"},{"key":"3201_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14082833","author":"V Mutruc","year":"2025","unstructured":"Mutruc V, Bologa C, \u0218orodoc V, Ceasovschih A, Mor\u0103ra\u0219u BC, \u0218orodoc L, et al. Cardiovascular-Kidney-Metabolic syndrome: a new paradigm in clinical medicine or going back to basics? J Clin Med. 2025. https:\/\/doi.org\/10.3390\/jcm14082833.","journal-title":"J Clin Med"},{"issue":"1","key":"3201_CR75","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","volume":"17","author":"V Ormazabal","year":"2018","unstructured":"Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zu\u00f1iga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3201_CR76","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","volume":"21","author":"LC Tao","year":"2022","unstructured":"Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3201_CR77","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4103\/bc.bc_32_24","volume":"11","author":"J Li","year":"2025","unstructured":"Li J, Zhao S, Zhang X, Fan M, Wan J, Lin R, et al. Association of systemic inflammatory response index with the cardiometabolic multimorbidity among US adults: a population-based study. Brain Circ. 2025;11(1):39\u201347.","journal-title":"Brain Circ"},{"key":"3201_CR78","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m131","volume":"368","author":"GD Batty","year":"2020","unstructured":"Batty GD, Gale CR, Kivim\u00e4ki M, Deary IJ, Bell S. Comparison of risk factor associations in UK Biobank against representative, general population based studies with conventional response rates: prospective cohort study and individual participant meta-analysis. BMJ. 2020;368:m131.","journal-title":"BMJ"},{"issue":"7","key":"3201_CR79","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/s41562-023-01579-9","volume":"7","author":"T Schoeler","year":"2023","unstructured":"Schoeler T, Speed D, Porcu E, Pirastu N, Pingault JB, Kutalik Z. Participation bias in the UK Biobank distorts genetic associations and downstream analyses. Nat Hum Behav. 2023;7(7):1216\u201327.","journal-title":"Nat Hum Behav"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03201-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03201-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03201-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:10:09Z","timestamp":1782792609000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03201-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3201"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03201-4","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Northwest Multi-center Research Ethics Committee (MREC reference: 21\/NW\/0157) provided ethical approval for the UK Biobank project. All participants gave informed consent before being recruited.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"187"}}